Full View

Prevalence and predictors of peripheral neuropathy after breast cancer treatment

M Kamgar, MK Greenwald, H Assad… - Cancer …, 2021 - Wiley Online Library
Background Many of the 3.8 million breast cancer survivors in the United States experience
long‐term side effects of cancer therapy including peripheral neuropathy (PN). We assessed …
被引用次数：29 相关文章

Prevalence and predictors of peripheral neuropathy after breast cancer treatment

M Kamgar, MK Greenwald, H Assad… - Cancer …, 2021 - search.proquest.com
Background Many of the 3.8 million breast cancer survivors in the United States experience
long‐term side effects of cancer therapy including peripheral neuropathy (PN). We assessed …
[HTML] nih.gov

[HTML][HTML] Prevalence and predictors of peripheral neuropathy after breast cancer treatment

M Kamgar, MK Greenwald, H Assad, TA Hastert… - Cancer …, 2021 - ncbi.nlm.nih.gov
Background Many of the 3.8 million breast cancer survivors in the United States experience
long‐term side effects of cancer therapy including peripheral neuropathy (PN). We assessed …

Prevalence and predictors of peripheral neuropathy after breast cancer treatment.

M Kamgar, MK Greenwald, H Assad, TA Hastert… - Cancer …, 2021 - europepmc.org
Background Many of the 3.8 million breast cancer survivors in the United States experience
long-term side effects of cancer therapy including peripheral neuropathy (PN). We assessed …

Prevalence and predictors of peripheral neuropathy after breast cancer treatment

M Kamgar, MK Greenwald, H Assad… - Cancer …, 2021 - ohiostate.elsevierpure.com
Background: Many of the 3.8 million breast cancer survivors in the United States experience
long-term side effects of cancer therapy including peripheral neuropathy (PN). We assessed …

Prevalence and predictors of peripheral neuropathy after breast cancer treatment

M Kamgar, MK Greenwald, H Assad… - Cancer …, 2021 - pubmed.ncbi.nlm.nih.gov
Background Many of the 3.8 million breast cancer survivors in the United States experience
long-term side effects of cancer therapy including peripheral neuropathy (PN). We assessed …

Prevalence and predictors of peripheral neuropathy after breast cancer treatment.

M Kamgar, MK Greenwald, H Assad… - Cancer …, 2021 - search.ebscohost.com
Abstract Background: Many of the 3.8 million breast cancer survivors in the United States
experience long‐term side effects of cancer therapy including peripheral neuropathy (PN) …

Prevalence and predictors of peripheral neuropathy after breast cancer treatment

M Kamgar, MK Greenwald, H Assad… - Cancer medicine …, 2021 - scholarship.miami.edu
Background Many of the 3.8 million breast cancer survivors in the United States experience
long‐term side effects of cancer therapy including peripheral neuropathy (PN). We assessed …
[PDF] lymphoedemaeducation.com.au

[PDF][PDF] Prevalence and predictors of peripheral neuropathy after breast cancer treatment

M Kamgar, MK Greenwald, H Assad, TA Hastert… - 2021 - lymphoedemaeducation.com.au
Abstract Background: Many of the 3.8 million breast cancer survivors in the United States
experience long-term side effects of cancer therapy including peripheral neuropathy (PN) …